MapLight Therapeutics (MPLT) Change in Accured Expenses (2024 - 2025)
MapLight Therapeutics (MPLT) posted Change in Accured Expenses of $1.1 million for Q4 2025, down 6.72% sequentially from $1.2 million in Q4 2024, and down 6.72% YoY from $1.2 million in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Change in Accured Expenses (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Change in Accured Expenses for 2 years, with the latest figure at $1.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | MapLight Therapeutics | 642.40 Mn | 642.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Dec 31, 2024 | 1.21 Mn |